Cefadroxil
- Product NDC
- 0093-3196
- 11-digit product format
- 000933196
- Labeler code
- 0093
- Product ID
- 0093-3196_86b8951f-3699-4888-9eeb-7bbda995ec35
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefadroxil
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA065282
- Marketing category
- ANDA
- Marketing start
- 2007-01-31
- Substance
- CEFADROXIL
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cefadroxil
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CEFADROXIL | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 280111G160 |
| Rxcui | 309049 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0093-3196-01 | Cefadroxil | 100 in 1 BOTTLE | CAPSULE | 100 | | 15 |
| 0093-3196-53 | Cefadroxil | 50 in 1 BOTTLE | CAPSULE | 50 | | 15 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CEFADROXIL | ACTIVE INGREDIENT | 280111G160 | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| CEFADROXIL ANHYDROUS | ACTIVE MOIETY | Q525PA8JJB | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| INDIGOTINDISULFONATE SODIUM | INACTIVE INGREDIENT | D3741U8K7L | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA INC] | 8 | |
| CEFADROXIL | ACTIVE INGREDIENT | 280111G160 | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| CEFADROXIL ANHYDROUS | ACTIVE MOIETY | Q525PA8JJB | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CEFADROXIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0093-3196 | CEFADROXIL CAPSULE [TEVA PHARMACEUTICALS USA, INC.] | 15 | Current NDC, Legacy NDC, 2 package rows | 20250306_bda86975-8c2f-4c4e-9a4c-a1a959f9336a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-3196-01 | 00093319601 | 100 CAPSULE in 1 BOTTLE (0093-3196-01) | 100 capsule | 2007-01-31 | 0000-00-00 | No | No | Current |
| 0093-3196-53 | 00093319653 | 50 CAPSULE in 1 BOTTLE (0093-3196-53) | 50 capsule | 2007-01-31 | 0000-00-00 | No | No | Current |